GSK_Annual_Report_2021

Annual Report 2020-21 171 The accompanying notes 1 to 57 are an integral part of the Consolidated Financial Statements In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants R. S. Karnad Chairperson DIN: 00008064 S. Venkatesh Managing Director DIN: 07263117 Rupen K. Bhatt P. Thakur CFO & Whole-time Director DIN: 07971789 Partner D. Sundaram Audit Committee Chairman DIN: 00016304 A. Nadkarni Company Secretary FCS 10460 Mumbai, May 18, 2021 Mumbai, May 18, 2021 ( ` in lakhs) Notes Year ended March 31, 2021 Year ended March 31, 2020 Revenue from operations 26 3198,86.22 3224,38.07 Other income 27 110,58.27 79,01.24 Total income 3309,44.49 3303,39.31 Expenses Cost of materials consumed 28 472,02.47 474,37.97 Purchases of stock-in-trade 880,11.32 868,92.28 Changes in inventories of finished goods, stock-in-trade and work-in-progress 29 (39,42.72) (35,43.27) Employee benefits expense 30 614,68.79 628,55.35 Finance costs 31 3,53.14 6,33.55 Depreciation and amortisation expense 32 79,28.36 82,67.77 Other expenses 33 576,13.61 630,71.04 Total expenses 2586,34.97 2656,14.69 Profit before exceptional items and tax 723,09.52 647,24.62 Exceptional items (net) 37 (172,59.69) (341,49.31) Profit before tax 550,49.83 305,75.31 Tax expense: Current tax 45 184,30.17 235,31.46 Deferred tax 45 8,04.93 (47,62.23) Tax adjustment of earlier year - 24,85.62 192,35.10 212,54.85 Profit for the year 358,14.73 93,20.46 Other comprehensive income / (loss) Items that will not be reclassified to profit or loss Remeasurement of defined benefit plans 45 (2,73.74) (4,56.06) Investments written off - (5.50) Income tax relating to items that will not be reclassified to profit or loss 45 68.90 64.27 (2,04.84) (3,97.29) Total comprehensive income for the year 356,09.89 89,23.17 Profit for the year attributable to owners of the Company 358,14.73 93,20.46 Other comprehensive income / (loss) attributable to owners of the Company (2,04.84) (3,97.29) Total comprehensive income for the year attributable to owners of the Company 356,09.89 89,23.17 Earnings per equity share 47 Basic and diluted earnings per share before exceptional item 31.35 26.70 Basic and diluted earnings per share after exceptional item 21.14 5.50 Consolidated Statement of Profit and Loss for the year ended March 31, 2021